• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年轻绝经后女性激素治疗与死亡率的贝叶斯荟萃分析。

Bayesian meta-analysis of hormone therapy and mortality in younger postmenopausal women.

作者信息

Salpeter Shelley R, Cheng Ji, Thabane Lehana, Buckley Nicholas S, Salpeter Edwin E

机构信息

Santa Clara Valley Medical Center, 751 S. Bascom Ave, San Jose, CA 95128, USA.

出版信息

Am J Med. 2009 Nov;122(11):1016-1022.e1. doi: 10.1016/j.amjmed.2009.05.021.

DOI:10.1016/j.amjmed.2009.05.021
PMID:19854329
Abstract

BACKGROUND

There is uncertainty over the risks and benefits of hormone therapy. We performed a Bayesian meta-analysis to evaluate the effect of hormone therapy on total mortality in younger postmenopausal women. This analysis synthesizes evidence from different sources, taking into account varying views on the issue.

METHODS

A comprehensive search from 1966 through January 2008 identified randomized controlled trials of at least 6 month's duration that evaluated hormone therapy in women with mean age <60 years and reported at least one death, and prospective observational cohort studies that evaluated the relative risk of mortality associated with hormone therapy after adjustment for confounding variables.

RESULTS

The results were synthesized using a hierarchical random-effects Bayesian meta-analysis. The pooled results from 19 randomized trials, with 16,000 women (mean age 55 years) followed for 83,000 patient-years, showed a mortality relative risk of 0.73 (95% credible interval 0.52-0.96). When data from 8 observational studies were added to the analysis, the resultant relative risk was 0.72 (credible interval 0.62-0.82). The posterior probability that hormone therapy reduces total mortality in younger women is almost 1.

CONCLUSIONS

The synthesis of data using Bayesian meta-analysis indicates a reduction in mortality in younger postmenopausal women taking hormone therapy compared with no treatment. This finding should be interpreted taking into account the potential benefits and harms of hormone therapy.

摘要

背景

激素疗法的风险和益处尚不确定。我们进行了一项贝叶斯荟萃分析,以评估激素疗法对绝经后年轻女性全因死亡率的影响。该分析综合了来自不同来源的证据,同时考虑了对此问题的不同观点。

方法

全面检索1966年至2008年1月期间的文献,确定了至少为期6个月的随机对照试验,这些试验评估了平均年龄<60岁女性的激素疗法,并报告了至少一例死亡病例;以及前瞻性观察队列研究,这些研究评估了在调整混杂变量后与激素疗法相关的死亡相对风险。

结果

采用分层随机效应贝叶斯荟萃分析对结果进行综合。19项随机试验的汇总结果显示,16000名女性(平均年龄55岁)随访了83000患者年,死亡相对风险为0.7(95%可信区间0.52 - 0.96)。当将8项观察性研究的数据加入分析时,最终相对风险为0.72(可信区间0.62 - 0.82)。激素疗法降低年轻女性全因死亡率的后验概率几乎为1。

结论

使用贝叶斯荟萃分析对数据进行综合表明,与未接受治疗相比,接受激素疗法的绝经后年轻女性死亡率降低。应结合激素疗法的潜在益处和危害来解读这一发现。

相似文献

1
Bayesian meta-analysis of hormone therapy and mortality in younger postmenopausal women.年轻绝经后女性激素治疗与死亡率的贝叶斯荟萃分析。
Am J Med. 2009 Nov;122(11):1016-1022.e1. doi: 10.1016/j.amjmed.2009.05.021.
2
Mortality associated with hormone replacement therapy in younger and older women: a meta-analysis.年轻女性和老年女性激素替代疗法相关死亡率的荟萃分析。
J Gen Intern Med. 2004 Jul;19(7):791-804. doi: 10.1111/j.1525-1497.2004.30281.x.
3
[Meta-analysis of the Italian studies on short-term effects of air pollution].[意大利关于空气污染短期影响研究的荟萃分析]
Epidemiol Prev. 2001 Mar-Apr;25(2 Suppl):1-71.
4
Hormone replacement therapy among postmenopausal women presenting with acute myocardial infarction: insights from the GUSTO-III trial.绝经后女性急性心肌梗死后的激素替代治疗:来自 GUSTO-III 试验的见解。
Am Heart J. 2010 Oct;160(4):678-84. doi: 10.1016/j.ahj.2010.06.030.
5
Postmenopausal hormone therapy and mortality.绝经后激素治疗与死亡率
N Engl J Med. 1997 Jun 19;336(25):1769-75. doi: 10.1056/NEJM199706193362501.
6
Hormone therapy for younger postmenopausal women: how can we make sense out of the evidence?年轻绝经后女性的激素治疗:我们如何理解这些证据?
Climacteric. 2005 Dec;8(4):307-10. doi: 10.1080/13697130500345505.
7
The long-term impact of 2-3 years of hormone replacement therapy on cardiovascular mortality and atherosclerosis in healthy women.2至3年激素替代疗法对健康女性心血管死亡率和动脉粥样硬化的长期影响。
Climacteric. 2006 Apr;9(2):108-18. doi: 10.1080/13697130600647743.
8
Postmenopausal hormone therapy and risk of developing urinary incontinence.绝经后激素治疗与尿失禁发生风险
Obstet Gynecol. 2004 Feb;103(2):254-60. doi: 10.1097/01.AOG.0000107290.33034.6f.
9
Menopause and stroke and the effects of hormonal therapy.绝经、中风与激素疗法的影响
Climacteric. 2007 Oct;10 Suppl 2:27-31. doi: 10.1080/13697130701550903.
10
Treatment adherence in the Estonian postmenopausal hormone therapy (EPHT) trial [ISRCTN35338757].爱沙尼亚绝经后激素治疗(EPHT)试验[ISRCTN35338757]中的治疗依从性。
Maturitas. 2005 Nov-Dec;52(3-4):286-95. doi: 10.1016/j.maturitas.2005.05.001. Epub 2005 Aug 1.

引用本文的文献

1
Menopausal hormone therapy shows superior efficacy to complementary and alternative medicine in treating symptomatic hand osteoarthritis in Japanese women during perimenopause.在治疗围绝经期日本女性有症状的手部骨关节炎方面,绝经激素疗法比补充和替代医学显示出更高的疗效。
Womens Health (Lond). 2025 Jan-Dec;21:17455057251359384. doi: 10.1177/17455057251359384. Epub 2025 Jul 31.
2
Detailed statistical analysis plan for a secondary Bayesian analysis of the SafeBoosC-III trial: a multinational, randomised clinical trial assessing treatment guided by cerebral oximetry monitoring versus usual care in extremely preterm infants.SafeBoosC-III 试验二次贝叶斯分析的详细统计分析计划:一项评估在极早产儿中通过脑氧监测指导治疗与常规护理的多中心随机临床试验。
Trials. 2023 Nov 16;24(1):737. doi: 10.1186/s13063-023-07720-3.
3
Systematic review and meta-analysis of the effects of menopause hormone therapy on risk of Alzheimer's disease and dementia.绝经激素治疗对阿尔茨海默病和痴呆症风险影响的系统评价与荟萃分析
Front Aging Neurosci. 2023 Oct 23;15:1260427. doi: 10.3389/fnagi.2023.1260427. eCollection 2023.
4
'Tis but a scratch: a critical review of the Women's Health Initiative evidence associating menopausal hormone therapy with the risk of breast cancer.这只是一个划痕:对与绝经激素治疗与乳腺癌风险相关的妇女健康倡议证据的批判性回顾。
Menopause. 2023 Dec 1;30(12):1241-1245. doi: 10.1097/GME.0000000000002267. Epub 2023 Oct 18.
5
Aging under endocrine hormone regulation.内分泌激素调节下的衰老。
Front Endocrinol (Lausanne). 2023 Aug 2;14:1223529. doi: 10.3389/fendo.2023.1223529. eCollection 2023.
6
Rethinking Menopausal Hormone Therapy: For Whom, What, When, and How Long?重新思考更年期激素治疗:针对谁、什么、何时以及多长时间?
Circulation. 2023 Feb 14;147(7):597-610. doi: 10.1161/CIRCULATIONAHA.122.061559. Epub 2023 Feb 13.
7
Postmenopausal hormone therapy and mortality before and after the Women's Health Initiative study.绝经后激素治疗与妇女健康倡议研究前后的死亡率。
Sci Rep. 2023 Jan 11;13(1):539. doi: 10.1038/s41598-023-27731-z.
8
Roles of Hormone Replacement Therapy and Menopause on Osteoarthritis and Cardiovascular Disease Outcomes: A Narrative Review.激素替代疗法和绝经对骨关节炎及心血管疾病结局的作用:一项叙述性综述
Front Rehabil Sci. 2022 Mar 28;3:825147. doi: 10.3389/fresc.2022.825147. eCollection 2022.
9
Ovarian steroid hormones: A long overlooked but critical contributor to brain aging and Alzheimer's disease.卵巢甾体激素:长期被忽视却对大脑衰老和阿尔茨海默病起关键作用的因素。
Front Aging Neurosci. 2022 Jul 19;14:948219. doi: 10.3389/fnagi.2022.948219. eCollection 2022.
10
Menopausal Hormone Replacement Therapy and Reduction of All-Cause Mortality and Cardiovascular Disease: It Is About Time and Timing.绝经后激素替代治疗与全因死亡率和心血管疾病的降低:这关乎时机。
Cancer J. 2022;28(3):208-223. doi: 10.1097/PPO.0000000000000591.